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Abstract CD38 is a transmembrane glycoprotein involved as an 
orphan receptor in many physiological processes of lymphocytes. 
It is also a bifunctional enzyme that catalyzes at its ectocellular 
domain the synthesis from NAD + (cyclase) and the hydrolysis 
(hydrolase) of the calcium-mobilizing metabolite cyclic ADP- 
ribose (cADPR). A still unexplained paradox concerns the 
relationship between ectocellular localization of CD38 and 
intracellular calcium-releasing activity of its intermediate 
product cADPR. Incubation of CD38 + human Namalwa B cells 
with external NAD + elicited extensive membrane down-regula- 
tion of CD38 and its internalization in non-clathrin-coated 
vesicles. Since the internalized CD38 was demonstrated to be 
enzymatically active, this NAD+-dependent process is a hitherto 
unrecognized means for shifting cADPR metabolism from the 
cell surface to the intracellular environment. 
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1. Introduction 
CD38 is a type II transmembrane glycoprotein predomi- 
nantly expressed in early and late stages of lymphocyte devel- 
opment [1,2]. Its involvement in many processes of lympho- 
cyte proliferation and differentiation as a receptor for still 
unidentified ligand(s) is supported by a wide range of effects 
on lymphocyte physiology elicited by ligation of CD38 with 
specific monoclonal antibodies (MoAbs) [1,2]. 
CD38 is also a bifunctional ectoenzyme that catalyzes, at 
the outer surface of many cell types [3], the sequential syn- 
thesis and degradation of cyclic ADP-ribose (cADPR) [4-8]: 
the two enzyme activities involved are an ADP-ribosyl cyclase 
(responsible for the conversion of NAD + to nicotinamide and 
cADPR) and a cADPR hydrolase that degrades cADPR to 
ADP-ribose (ADPR). 
The potent calcium-releasing activity of cADPR on ryano- 
dine-sensitive intracellular stores in several invertebrate and 
vertebrate cells [9 11] has raised expectations that this cyclic 
nucleotide may play a role in mediating CD38 receptor func- 
tions. An enhanced transmembrane calcium influx has been 
detected in murine B cells [12] following ligation with anti- 
CD38 antibodies, but there is no evidence that cADPR is 
involved. 
*Corresponding author. Fax: (39) (10) 354415. 
Abbreviations: cADPR, cyclic ADP-ribose; ADPR, ADP-ribose; 
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A major, still unresolved question on the CD38-cADPR 
system concerns the apparent contradiction between the ecto- 
cellular site of CD38-catalyzed production of cADPR and its 
intracellular calcium-mobilizing activity [2,11,13,14]. Neither 
cADPR influx across the plasma membrane nor cADPR-in- 
itiated signal transduction in responsive cells has been demon- 
strated so far, although external cADPR has been reported to 
enhance the proliferation of activated murine B lymphocytes 
[4]. In addition, extracellular cADPR has been recently dem- 
onstrated to enhance the calcium response to depolarization 
in intact rat cerebellar granule cells [15]. 
An alternative mechanism for coupling the extracellular 
synthesis of cADPR with its intracellular functions could be 
the internalization of CD38. We have previously demon- 
strated that CD38, both purified from human erythrocyte 
ghosts and in situ in erythrocyte membranes, undergoes ex- 
tensive self-aggregation i the presence of either thiol com- 
pounds or NAD + [13,16,17]. Since ligand-induced receptor 
oligomerization is known to trigger subsequent internalization 
[18,19], we investigated the fate of membrane CD38 following 
exposure of intact CD38 + Namalwa cells (a continuous B-cell- 
derived line from Burkitt's lymphoma) to NAD + or GSH. 
The data provided in this paper indicate that incubation of 
these cells with either reagent results in the cell surface deple- 
tion of CD38. Concomitantly, NAD + proved to induce CD38 
internalization i these cells. This process, coupling down-reg- 
ulation of surface CD38 with increased intracellular cyclase 
activity, may provide a hitherto unrecognized mechanism un- 
derlying CD38 functions. 
2. Materials and methods 
2.1. Materials 
Nitrocellulose membranes for ECL were purchased from Amer- 
sham, Milan, Italy. The IB4 MoAb [20] was a kind gift by Professor 
F. Malavasi. All chemicals were of the highest purity grade available 
from Sigma Chem Co., St. Louis, MO. 
2.2. Cell culture 
Namalwa cells (obtained from American Type Culture Collection 
(ATCC) Bethesda, MD) were grown in RPMI (Sigma) supplemented 
with 10% fetal calf serum (Sigma), penicillin (1 U/ml) and streptomy- 
cin (1 ~g/ml) at 37°C in a humidified atmosphere with 5% CO2. When 
incubated in the presence of NAD +, cells were seeded at 5 × 10'S/ml 
and cultured for up to 18 h. Cell density never exceeded 1.5 × 106/ml 
and cell viability was >90%. No apparent inhibition of cell growth 
was observed in the presence of NAD +. 
2.3. Flow cytometry 
This was performed as reported in the legend to Fig. 1, using a 
FACScan (Becton Dickinson, Milan, Italy). Five thousand events 
were analyzed per sample. 
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2.4. Biotinylation of Namalwa cells and affinity purification of 
biotinylated CD38 
Cells were washed in RPMI without serum and incubated at 4°C in 
PBS containing 5 mM glucose, 0.1 mM CaC12, 1 mM MgCI2 and 0.8 
mM NHS-SS-biotin (Pierce, Milan, Italy) at a density of 5× 10;'/ml 
[21]. After 20 min cells were centrifuged and the incubation repeated 
with a new solution. Cells were then washed twice in RPMI contain- 
ing 0.2% BSA (fatty acid free), resuspended in complete medium at a 
density of 5 x 10~/ml and cultured in the presence or absence (control) 
of 10 mM NAD + for 18 h. In a typical experiment, 1.5× 107 cells 
were used for each incubation. Removal of surface biotin from con- 
trol and NAD+-treated cells was obtained by incubating the cells at 
37°C in RPMI with 50 mM GSH at a density of 106/ml for 5 rain. 
This procedure was repeated twice. To remove unreacted GSH. cells 
were then washed twice in PBS containing 5 mg/ml iodoacetamide and 
once in RPMI. Finally, cells were solubilized at 1.5 x 107/ml in lysis 
buffer (PBS containing 1% Triton X-100, 5 mM EDTA, 10 ~tg/ml 
leupeptin, 50 lag/ml aprotinin, 250 ~tg/ml trypsin inhibitor) and cen- 
trifuged at 10000xg for 10 rain. The clear supernatants were incu- 
bated with immobilized streptavidin (Pierce), at 300 ~tl packed resin/ 
ml lysate, for 2 h at 4°C on a rotary shaker. The supernatants were 
recovered by centrifugation, the resin was washed in lysis buffer and 
the adsorbed (i.e. biotinylated) proteins were eluted with 0.1 M gly- 
cine, pH 2.0. The pH of the eluate was immediately neutralized with 1 
M Tris-HC1, pH 8.3, and eluates and supernatants from control and 
NAD+-treated cells were dialyzed overnight at 4°C against 5 mM 
Tris-HC1, pH 6.5, containing 0.05% Triton X-100, and concentrated 
to 1/10 the original volume. Protein concentration was determined 
according to Bradford [22] with the appropriate detergent concentra- 
tions in the blank and standard reagents. Each sample was then ana- 
lyzed by Western blot (following SDS-PAGE) and dot blot (see be- 
low). 
2.5. Western blot and dot blot 
SDS-PAGE was performed on 10% gels, according to [23], and 
proteins were blotted on nitrocellulose membranes as described in 
[13]. Saturation of the membranes and incubation with the first 
(IB4) and second Ab (anti-mouse IgG, Amersham, Milan, Italy) 
were performed following instructions of the Amersham ECL immu- 
nodetection kit. 
2.6. Assays of cyclase and hydrolase activities 
These were performed on intact cells as in [17], using 0.5 mM 
NGD + [24] and 0.5 mM cADPR, respectively, as substrates. Enzyme 
assays on solubilized cells (prepared either with 1% Triton X-100 or 
by freezing-thawing) were carried out as described in the legend to 
Table 1. 
2. 7. Immunofluorescence 
Visible pellets of Namalwa cells, either untreated or treated for 2 or 
6 h with 10 mM NAD +, were processed as described [25]. Briefly, cells 
were fixed in 3.7% paraformaldehyde in PBS, embedded at 4°C in 
ascending concentrations of sucrose in PBS, followed by OCT (Tis- 
sue-Tek, Miles Inc., Elkhart, IN) and frozen in liquid nitrogen. Sam- 
ples were then sectioned in a cryostat, laid on gelatin-coated glass 
slides and air dried. The primary IB4 antibody was used at 5 p.g/ml, 
the rabbit anti-clathrin antiserum (Sigma) was used at a 1:60 dilution. 
TRITC-conjugated goat anti-mouse or FITC-conjugated goat anti- 
rabbit IgG affinity purified antibodies (Jackson Immunoresearch, 
West Grove, PA) were used as secondary reagents. 
2.8. Cryoimmunoelectron microscopy 
Visible pellets of Namalwa cells, either untreated or treated for 2 or 
6 h with 10 mM NAD +, were processed as described [26]. All anti- 
bodies used were diluted in PBS, containing 0.02 M glycine. The 
primary IB4 antibody was used at 5 ~tg/ml. The second step reagent 
was a 10 nm gold-labeled goat anti-mouse lgG (ICN Biomedicals, 
Milan, Italy), diluted 1:50. The grids were observed and photo- 
graphed with a Zeiss EM 10/C electron microscope. 
3. Results 
We used both flow cytometry and assays of ectocellular 
cyclase and cADPR hydrolase activities to monitor surface 
CD38 upon incubation of intact Namalwa cells with either 
of the two CD38-clustering agents, NAD + or GSH 
[13,16,17]. In all experiments, both reagents were used at de- 
liberately high concentrations to obviate any instability 
(mostly due to enzymatic degradation of NAD + and to oxi- 
dation of GSH) over the incubation times required to induce 
the changes under study. However, 10-fold lower NAD + or 
GSH gave the same effects on ectocellular CD38 enzyme ac- 
tivities at the shortest incubation times. 
3.1. Cytofluorimetric analysis 
Following 3 h incubation of Namalwa cells in the presence 
of 10 mM NAD + the intensity of CD38 immunofluorescence, 
as detected with the IB4 MoAb,  was reduced to approxi- 
mately 30% (Fig. 1). The same result was obtained using 
two different anti-CD38 MAbs, IB6 and OKT10, which re- 
cognize different epitopes of the glycoprotein [27]. The inten- 
sity of cell surface immunofluorescence with an anti-HLA I 
MoAb was unaffected by treatment with NAD +. A compar- 
able extent of surface CD38 down-regulation was obtained 
upon exposure of the cells to 10 mM GSH (not shown). 
3.2. Assay of  ectocellular and total cyclase activities 
Cyclase activity of Namalwa cells was assayed on NGD +, 
to avoid interference by the cADPR hydrolase [13,24]. After 
2, 3 and 18 h incubation of the cells at 37°C with 10 mM 
NAD + (see Section 2.2), ectocellular cyclase activity decreased 
to 53+5%, 27+5% and 17+3% (mean+S.D.  of 5 experi- 
ments), respectively, of the value of control cells (3.66_+ 0.20 
nmol cGDPR/min/mg protein). A similar decay of the cyclase 
activity was observed upon culturing the cells with 10 mM 
GSH. With either reagent, disappearance of surface cyclase 
activity was closely paralleled by loss of the hydrolase. Re- 
moval of NAD + from the medium following 3 h incubation 
resulted in slow re-expression of membrane CD38, as shown 
by the increase of cyclase activity from 27 + 5% to 48 + 8% 
(mean + S.D. of 3 experiments) of control levels over 24 h at 
37°C. 
Cyclase activity was also assayed at the same times of in- 
Table 1 
Cyclase activity of intact and Triton X-100-solubilized Namalwa 
cells cultured with NAD + 
Incubation time (h) Total 
. . . .  cyclase activity X 100 
ec l ;oceun lar  
Control NAD + -treated 
0 138 140 
2 140 167 
2+Sucrose (0.45M) 141 168 
2+Cycloheximide (100 ~M) 142 165 
18 139 215 
Namalwa cells were cultured at 37°C and 5% CO2 in complete me- 
dium (5X l0 S cells/ml) with 10 mM NAD +. At the end of the 2 h 
incubation with NAD + and cycloheximide, protein synthesis was 90% 
inhibited as determined by TCA-insoluble [35S]Met incorporation. At 
the times indicated, cells were washed, resuspended in PBS with 10 
mM glucose at 10 6 cells/ml and divided into two aliquots: one was 
solubilized by addition of 1% Triton X-100 (solubilized cells), while 
the other received an equal volume of PBS (intact cells). Cyclase 
activity was assayed in both solubilized (total) and intact cells (ecto- 
cellular) with 0.5 mM NGD + as substrate. After 15 and 30 min in- 
cubation with NGD + at 37°C aliquots were withdrawn, deproteinized 
with TCA (5% final concentration), centrifuged and the excess TCA 
removed with diethylether. HPLC analysis was as in [17]. Results are 
the mean of 5 experiments (S.D. --< 12%). 
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Fig. 1. CD38 immunofluorescence of Namalwa cells incubated with 
NAD ~. Namalwa cells (5X 105 cells/ml) were cultured at 37°C and 
5% CO2, as described in Section 2.2, without (control) or with 10 
mM NAD +. After 5 h cells were washed and incubated in 50 /.tg/ml 
IB4 in complete medium for 30 min at 0°C. Thereafter, cells were 
washed and incubated with 50 ~g/ml FITC-conjugated anti-mouse 
IgG in complete medium for 30 min at 0°C, then washed again and 
fluorescence intensity was quantitated by flow cytometry. No fluo- 
rescence was detectable on cells incubated with the second antibody 
only (continuous line). Dotted line, control cells. Dashed line, 
NAD+-treated cells. Results of a typical experiment are shown. 
cubation in the corresponding solubilized cells (total activity) 
obtained with freezing-thawing or Triton X-100. The latter 
procedure proved to be more disruptive: thus, the ratios be- 
tween total and ectocellular cyclase activities in control cells 
were 1.15 + 0.04 (n = 4) and 1.40 + 0.06 (n = 6) for the frozen- 
thawed and the Triton X-100-treated cells, respectively. The 
ratio of total to ectocellular cyclase activity was consistently 
higher in the NAD+-treated than in the control cells and 
increased with the time of exposure to NAD + (Table 1). An 
actually higher intracellular cyclase activity in the cells ex- 
posed to NAD +, as compared to controls, is demonstrated 
by an increased cADPR content, estimated by a sensitive 
and specific R IA  procedure [28]. The relevant levels of 
cADPR were 3.13_+0.45 and 1.63_+0.24 pmol/mg protein in 
the perchloric acid extracts from NAD+-treated cells (2 h) and 
control cells, respectively, following extensive washing of the 
relevant cell populations. 
The presence of cycloheximide (100 ~tM) or hyperosmolar 
sucrose (0.45 M), an inhibitor of clathrin-dependent endocy- 
tosis [29], during incubation of the cells with NAD + did not 
exert any significant effect on the changes in the ratio of total 
to ectocellular cyclase activity (Table 1). 
No appreciable cyclase activity was detectable in the super- 
natants of NAD +- or GSH-treated cells throughout he incu- 
bation time. This rules out any shedding of CD38 under these 
conditions [30]. 
3.3. Internalization of  CD38 
To further confirm internalization of CD38 in NAD+-treat - 
ed Namalwa cells, cell surface biotinylation experiments were 
carried out. Thus, after cell biotinylation and subsequent 18 h 
culture in the absence (control) or presence of 10 mM NAD +, 
biotin was removed from surface proteins, the cells were sol- 
ubilized and the cell lysates were applied onto immobilized 
streptavidin (see Section 2.4). Supernatants and eluates from 
the affinity purification step, corresponding to ectocellular and 
to internalized, biotinylated proteins, respectively, were ana- 
lyzed both by dot blot and by SDS-PAGE followed by West- 
ern blot. Results are shown in Fig. 2. 
No CD38 was apparent in the streptavidin eluates from the 
control cell lysates, neither by dot blot (Fig. 2A, dot 2) nor by 
SDS-PAGE and Western blot (Fig. 2B, lane 2), while CD38 
could be clearly visualized in the streptavidin supernatants by 
dot blot (Fig. 2A, dot 1) and as a 46 kDa band by SDS- 
PAGE and Western blot (Fig. 2B, lane 1). These results iden- 
tify CD38 in control cell lysates as the unbiotinylated (i.e. 
membrane-bound) monomeric form only. Conversely, the 
streptavidin eluate from NAD+-treated cell lysates showed a 
strong immunoreactivity with the IB4 MoAb on dot blot 
analysis (Fig. 2A, dot 4), indicating the presence of biotinyl- 
ated (i.e. internalized) CD38 in the lysates. The absence of a 
46 kDa band on SDS-PAGE and Western blot lane from the 
same sample (Fig. 2B, lane 4) indicates that the internalized 
CD38 was in an aggregated form, unable to enter the poly- 
acrylamide gel [13,16]. Some residual, unbiotinylated (i.e. ec- 
tocellular) and monomeric CD38 was detectable in the lysates 
of NAD+-treated cells both by dot blot (Fig. 2A, dot 3) and 
by SDS-PAGE (Fig. 2B, lane 3), although the amount of 
CD38 was apparently lower than in lysates from control cells. 
Search of CD38 aggregates in the lysates from NAD+-treat - 
ed cells by means of density gradient centrifugation (both on 
1 2 3 4 
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Fig. 2. Aggregation and internalization of biotinylated CD38. Na- 
malwa cells were surface biotinylated as described in Section 2.4 
and cultured for 18 h in the absence (control) or presence of 10 
mM NAD +. After removal of surface biotin with a pulse of GSH, 
cells were washed and solubilized. Lysates from control and NAD ÷- 
treated cells were applied to immobilized streptavidin. Resin super- 
natants and eluates were concentrated and each sample was sub- 
jected to dot blot (A) and SDS-PAGE and Western blot (B). Immu- 
nodetection of CD38 was obtained with the IB4 MoAb and ECL. 
Results of a representative experiment are shown. 1, control super- 
natant; 2, control eluate; 3, supernatant from NAD+-treated cells; 
4, eluate from NAD+-treated cells. 




• , °  
Fig. 3. Internalization of CD38 via smooth vesicles upon incubation of Namalwa cells with NAD +. a, b, Immunofluorescence staining for 
CD38 of Namalwa cells either untreated (a) or treated for 2 h with 10 mM NAD ~ (b). a: In most control cells CD38 was localized on the out- 
er plasma membrane (arrow), but in a few cells a dot-like intracellular pattern of staining (arrowhead) was also evident, b: After NAD + treat- 
ment the plasma membrane localization disappeared, while all cells showed an intense dot-like intracellular staining (arrowhead). c, d: Ultra- 
structural immunogold localization of CD38 on ultrathin cryosections of Namalwa cells treated for 2 h with 10 mM NAD + revealed the 
presence of smooth vesicles containing old particles (arrows). Bar: a, 30 ~tm; b, 24 gm; c, 166 nm; d, 110 nm. 
sucrose and on glycerol) and of gel permeation experiments 
followed by dot blot assays on the individual fractions, was 
unsuccessful• The main reasons for these negative results 
were: (a) interference of sucrose and glycerol on the dot 
blot assays, even following dialysis of the fractions; (b) irre- 
versible adhesion of polymeric CD38 to the gel matrices used 
for gel permeation analyses; (c) the apparent polydispersity of 
CD38 aggregates, in agreement with the lack of discrete oli- 
gomerization forms of the purified self-aggregated glycopro- 
tein [16]. 
In order to define the pathway of CD38 internalization 
upon NAD + treatment, we performed immunofluorescence 
and cryoimmunoelectron microscopy studies• Fig. 3a shows 
the peripheral membrane localization of CD38 in untreated 
control cells. After 2 h (Fig. 3b) and 6 h (not shown) of 
exposure to NAD +, most CD38 disappeared from the cell 
membrane and was found in a dotted pattern of staining with- 
in the cytoplasm, indicating a possible vesicular localization. 
However, when cells were double immunostained for CD38 
and clathrin, the latter showed a more diffused and finely 
dispersed vesicular pattern of staining (not shown). After 2 
h exposure of the cells to NAD +, and more evidently after 6 
h, immunolocal izat ion at the ultrastructural level identified 
several CD38-containing cytoplasmic smooth vesicles (Fig. 
3c,d), with an average diameter of about 120-150 nm. These 
vesicles always contained more than one gold particle, indicat- 
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ing a possible clustering mechanism. In contrast, smooth ve- 
sicles containing gold particles were only exceptionally ob- 
served in control Namalwa cells (not shown). 
4. Discussion 
CD38 undergoes extensive aggregation upon incubation 
with either NAD + or thiol compounds [13,16,17]. The process 
is fast (less than 1 min) with the purified glycoprotein in 
solution, producing large aggregates with no apparent geome- 
try [13,16], while it is slower in membranes (10-60 rain), prob- 
ably due to impairment of lateral mobility. CD38 aggregation 
in membranes i accompanied by inability to enter polyacryl- 
amide gels. It takes place in human erythrocytes [17], human 
Molt-4 (a T cell line) and Swiss 3T3 murine fibroblasts trans- 
fected with human CD38 (E. Zocchi, unpublished). Therefore, 
NAD+-induced aggregation of CD38 seems to be related to 
the structure of the ectocellular region of the human glyco- 
protein [17] rather than to its membrane nvironment. 
In this study we obtained biochemical and morphological 
evidence for CD38 internalization i Namalwa B cells incu- 
bated with NAD +. The NAD+-induced endocytosis, which 
follows aggregation of membrane CD38 (Fig. 2), involves for- 
mation of membrane vesicles (Fig. 3). It does not take place 
through clathrin-coated pits, as demonstrated by the different 
patterns of staining of CD38 and clathrin, by failure of CD38 
to co-immunolocalize with clathrin by double immunofluores- 
cence staining and by lack of inhibition by hyperosmolar su- 
crose. It does not involve any formation of caveolae, because 
these structures are absent in lymphoid cells [31] and, addi- 
tionally, they are insoluble in Triton X-100 [32], which con- 
versely disrupts CD38-containing intracellular membrane ve- 
sicles quite efficiently (Table 1). Therefore, it is not yet 
possible to assess the nature of the endocytic vesicles involved 
in the process of NAD+-dependent CD38 internalization. 
It is worth noting that internalization of CD38 results in the 
import of ADP-ribosyl cyclase activity from the cell surface to 
the cytosol. This is demonstrated by the corresponding in- 
crease in cADPR levels in the NAD+-treated over the control 
cells. These findings do not necessarily contradict he large 
extent of enzyme inactivation by NAD + and by thiol com- 
pounds that occurs both with purified and with membrane- 
bound CD38 [13]. Indeed, the complexity of a whole cell with 
respect o purified or reconstructed systems does not allow an 
obvious comparison between in vitro and in vivo conditions. 
Specifically, in intact cells additional factors can limit enzyme 
inactivation, e.g. smaller aggregates, usceptibility to modula- 
tors, accelerated membrane-cytosol turnover of polymerized 
CD38. In any case, all the available data indicate that inter- 
nalized CD38 is responsible for the enhanced intracellular 
cyclase activity over that of control cells. The brief time of 
exposure to NAD + (2 h) sufficient to elicit the changes in 
subcellular localization, the failure of cycloheximide to inhibit 
this effect under conditions that effectively block protein 
synthesis (Table 1) and the slow turnover of membrane 
CD38 upon removal of NAD +, are evidence supporting inter- 
nalization rather than de novo synthesis of intracellular 
CD38. 
The present results indicate that extracellular NAD + could 
represent a hitherto unrecognized means for shifting cADPR 
metabolism from the cell surface to the intracellular compart- 
ment. This possibility would make it possible to reconcile the 
topological paradox of ectocellular localization of CD38 and 
intracellular site of action of its enzymatic product cADPR as 
a calcium mobilizer. Although, as pointed out in [2], endocy- 
tosis is expected to position the internalized CD38 within a 
membrane-bound intracellular vesicle (Fig. 3c,d), this seems 
to be accessible to cytosolic NAD +, as shown by the increase 
in cADPR levels. It has been speculated that extracellular 
NAD + might become available to CD38 + lymphoid cells, 
even at transiently elevated concentrations, following apopto- 
sis of neighboring cells [1,2]. Recently, NAD + has been de- 
tected for the first time in the interstitial fluid of rat cerebel- 
lum [15], thus adding to ATP [33] as a previously unidentified 
extracellular signal metabolite. GSH, which shows additive 
effects with NAD + in eliciting CD38 self-aggregation, might 
also be an extracellular ligand resulting from cell lysis and 
cooperating with NAD + in triggering CD38 internalization 
in responsive cells. 
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